This identification opens the door to future studies on the role of NAT synthesis in PUFA metabolism, as well as the roles of NATs in pathologies, such as fatty liver disease and diabetes, thus establishing the biological roles of these conserved lipids. This evidence concerns the gene BRD2 and diabetes mellitus.